These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5086955)

  • 1. Urinary elimination of phenethylamine.
    Fischer E; Spatz H; Saavedra JM; Reggiani H; Miró AH; Heller B
    Biol Psychiatry; 1972 Oct; 5(2):139-47. PubMed ID: 5086955
    [No Abstract]   [Full Text] [Related]  

  • 2. Phenethylamine content of human urine and rat brain, its alterations in pathological conditions and after drug administration.
    Fischer E; Spatz H; Heller B; Reggiani H
    Experientia; 1972 Mar; 28(3):307-8. PubMed ID: 5026444
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cerebral biochemical disorders and mental diseases. A propos of the "pink spot"].
    Delay J; Boissier JR; Deniker P; Simon P; Ginestet D; Wirz-Justice A
    Encephale; 1969; 58(4):360-76. PubMed ID: 5378191
    [No Abstract]   [Full Text] [Related]  

  • 4. Quantitative gas-chromatographic determination and infrared spectrographic identification of urinary phenethylamine.
    Fischer E; Spatz H; Fernández Labriola RS; Rodriguez Casanova EM; Spatz N
    Biol Psychiatry; 1973 Oct; 7(2):161-5. PubMed ID: 4748848
    [No Abstract]   [Full Text] [Related]  

  • 5. Ultraviolet spectrophotometric determination of 2-phenylethylamine in biological samples and its possible correlation with depression.
    Mosnaim AD; Inwang EE; Sugerman JH; DeMartini WJ; Sabelli HC
    Biol Psychiatry; 1973 Jun; 6(3):235-57. PubMed ID: 4732254
    [No Abstract]   [Full Text] [Related]  

  • 6. [Determination of a profile of the psychotropic action of noveril (dibenzepin) in depression syndromes using a clinico-statistical method].
    Zaĭtsev SG; Gromova VV; Khmelevskiĭ DL; Orlov VM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(4):574-83. PubMed ID: 5070026
    [No Abstract]   [Full Text] [Related]  

  • 7. [Surgical treatment of temporal lobe epilepsy in patients with marked mental disorders].
    Beĭn BN; Boreĭko VB
    Vopr Neirokhir; 1972; 36(2):26-31. PubMed ID: 5072637
    [No Abstract]   [Full Text] [Related]  

  • 8. Phenethylamine as a neurohumoral agent in brain.
    Fischer E; Heller B
    Behav Neuropsychiatry; 1972; 4(3-4):8-11 passim. PubMed ID: 4403640
    [No Abstract]   [Full Text] [Related]  

  • 9. [Interictal psychopathologic manifestations in epileptics].
    Barraquer-Bordas L
    Med Clin (Barc); 1985 Jun; 85(3):114-7. PubMed ID: 4021625
    [No Abstract]   [Full Text] [Related]  

  • 10. Schizophrenia and pink spot.
    Stam FC; Heslinga FJ; van Tilburg W
    Psychiatr Neurol Neurochir; 1969; 72(6):513-24. PubMed ID: 5369242
    [No Abstract]   [Full Text] [Related]  

  • 11. Phenethylamine in normal urine: failure to verify high values.
    Schweitzer JW; Friedhoff AJ; Schwartz R
    Biol Psychiatry; 1975 Jun; 10(3):277-85. PubMed ID: 1095082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative investigation on the urinary excretion and metabolism of 3,4-dimethoxyphenylethylamine in schizophrenics and normal individuals.
    Hempel K; Ullrich H; Philippu G
    Biol Psychiatry; 1982 Jan; 17(1):49-59. PubMed ID: 7059639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hallucinogen excretion in untreated psychiatric patients].
    Kanabus P; Krysa G; Matsumoto H
    Psychiatr Pol; 1973; 7(5):517-23. PubMed ID: 4520107
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative clinical experiences with dibenzazepine and dibenzodiazepine derivatives].
    Battegay R; Poeldinger W
    Arzneimittelforschung; 1967 Apr; 17(4):481-3. PubMed ID: 5632442
    [No Abstract]   [Full Text] [Related]  

  • 15. [Phenylethylamine in the urine of mental patients].
    Fischer E; Heller B; Miro AH
    Prensa Med Argent; 1968 Aug; 55(25):1193-5. PubMed ID: 5709487
    [No Abstract]   [Full Text] [Related]  

  • 16. Diminution of phenethylamine in the urine of Parkinson patients.
    Heller B; Fischer E
    Arzneimittelforschung; 1973 Jun; 23(6):884-6. PubMed ID: 4740778
    [No Abstract]   [Full Text] [Related]  

  • 17. Behavioral alterations in a mouse model of temporal lobe epilepsy induced by intrahippocampal injection of kainate.
    Gröticke I; Hoffmann K; Löscher W
    Exp Neurol; 2008 Sep; 213(1):71-83. PubMed ID: 18585709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of psychosis in epilepsy: laterality and forced normalization.
    Flor-Henry P
    Biol Psychiatry; 1983 Sep; 18(9):1045-57. PubMed ID: 6357300
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta-phenylethylamine in human urine.
    Fischer E; Heller B; Miró AH
    Arzneimittelforschung; 1968 Nov; 18(11):1486. PubMed ID: 5755919
    [No Abstract]   [Full Text] [Related]  

  • 20. [Urinary excretion of bufotenin, N,N-dimethyltryptamine and 3,4-dimethoxyphenylethylamine and the clinical picture of mental disorders].
    Matsumoto H; Pietruszewska I
    Psychiatr Pol; 1978; 12(2):189-97. PubMed ID: 275869
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.